Identification of Escherichia coli 166 isolate as an effective inhibitor of African swine fever virus replication
Microbiology Spectrum · 2025
DOI: 10.1128/spectrum.03009-24 ↗Kurz gefasst
Fachartikel in der Zeitschrift Microbiology Spectrum, 2025. Verfasst von Jinya Zhang und 9 weiteren Autor:innen. Beteiligte Einrichtung: State Key Laboratory for Animal Disease Prevention and Control, National High Containment Facilities for Animal Diseases Control and Prevention, Nati…. Hauptthemen laut MEDLINE: African Swine Fever Virus, Virus Replication, Escherichia coli, African Swine Fever. Die Arbeit nennt 50 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Heilongjiang Provincial Natural Science Foundation of China, MOST | National Key Research and Development Program of China (NKPs), Innovation Program of Chinese Academy of Agricultural Sciences.
Abstract (Originalsprache)
African swine fever is a lethal disease with mortality rates approaching 100% in both domestic pigs and wild boars. With no effective vaccines or treatments available, there is an urgent need for new biologics to combat the African swine fever virus (ASFV). In this study, we isolated bacteria from the intestinal contents of wild boar using culture-based methods and identified them through 16S ribosomal DNA (rDNA) sequencing. These isolates underwent high-throughput screening to evaluate their immunomodulatory effects on J774-Dual cells and their ability to inhibit ASFV replication in vitro . Among them, an Escherichia coli strain, designated as E. coli 166, exhibited strong inhibitory effects on various ASFV strains’ replication, including three genotype II strains: virulent strain HLJ/18, moderately virulent strain HLJ/HRB1/20, genetically modified low-virulent strain HLJ/18–6GD, and one genotype I low-virulent strain SD/DY-I/21. Notably, this inhibition did not require direct interaction between the bacteria and porcine alveolar macrophages (PAMs). Both live and heat-inactivated E. coli 166 demonstrated a strong inhibitory effect on ASFV replication. Genetic modification of E. coli 166 did not alter its inhibitory phenotype. Further analysis revealed that PAMs pretreated with E. coli 166 showed upregulation of NF-κB and downregulation of CD163 at different time points post-infection, whereas PAMs only infected with ASFV exhibited the opposite trend. These findings suggest that E. coli 166 holds promise as a biological agent for controlling ASFV infection, through indirect mechanisms involving bacterial metabolites or lysis products. Future studies should focus on identifying the specific components responsible for its antiviral effects. IMPORTANCE The emergence of the African swine fever virus (ASFV) as a devastating pathogen in swine populations necessitates the development of novel strategies for its control. In this study, Escherichia coli strain 166 ( E. coli 166) demonstrated a remarkable ability to inhibit the replication of multiple ASFV strains in porcine alveolar macrophages (PAMs), even without direct bacterial contact. Both live and heat-inactivated E. coli 166 retained this inhibitory effect, suggesting that secreted metabolites or lysis products may play a key role. Furthermore, pretreatment of PAMs with E. coli 166 resulted in upregulated NF-κB activity and downregulated expression of the ASFV entry receptor CD163, presenting an immune-modulatory mechanism distinct from PAMs solely infected with ASFV. These findings highlight the potential of E. coli 166 as a biological agent to combat ASFV, offering a promising alternative or complementary approach to traditional antiviral strategies.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- State Key Laboratory for Animal Disease Prevention and Control, National High Containment Facilities for Animal Diseases Control and Prevention, National African Swine Fever Para-reference Laboratory, Harbin Veterinary…
ORCID-Profile: Jinya Zhang, Zhigao Bu, Dongming Zhao
Förderung
- Heilongjiang Provincial Natural Science Foundation of China
- MOST | National Key Research and Development Program of China (NKPs)
- Innovation Program of Chinese Academy of Agricultural Sciences
- Central Public-interest Scientific Institution Basal Research Fund
Zitieren
APA
Zhang, J., Cui, H., Zhang, Z., Wang, W., Jiang, F., Sun, E., Zhu, Y., Li, F., Bu, Z., & Zhao, D. (2025). Identification of Escherichia coli 166 isolate as an effective inhibitor of African swine fever virus replication. Microbiology Spectrum. https://doi.org/10.1128/spectrum.03009-24
Vancouver
Zhang J, Cui H, Zhang Z, Wang W, Jiang F, Sun E, et al. Identification of Escherichia coli 166 isolate as an effective inhibitor of African swine fever virus replication. Microbiology Spectrum. 2025. doi:10.1128/spectrum.03009-24
BibTeX
@article{Zhang2025,
author = {Zhang, Jinya and Cui, Hongyu and Zhang, Zhenjiang and Wang, Wenqing and Jiang, Fengwei and Sun, Encheng and Zhu, Yuanmao and Li, Fang and Bu, Zhigao and Zhao, Dongming},
title = {Identification of Escherichia coli 166 isolate as an effective inhibitor of African swine fever virus replication},
journal = {Microbiology Spectrum},
year = {2025},
doi = {10.1128/spectrum.03009-24}
}
EUVIMED